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Abstract
Objective: To compare the prevalence of gynaecological conditions among HIV infected and non-
infected pregnant women.
Methods: Two thousand and eight (2008) pregnant women were screened for HIV, lower genital
tract infections and lower genital tract neoplasia at booking antenatal visit.
Results: About 10% (198/2008) were HIV positive. All lower genital tract infections except
candidiasis were more prevalent among HIV positive compared to HIV negative women: vaginal
candidiasis (36.9% vs 35.4%; p = 0.678), Trichomoniasis (21.2% vs 10.6%; p < 0.001), gonorrhoea
(10.1% vs 2.5%; p < 0.001), bacterial vaginosis (21.2% vs 15.2%; p = 0.026), syphilis (35.9% vs 10.6%;
p < 0.001), and Chlamydia trachomatis (38.4% vs 7.1%; p < 0.001). Similarly, HIV positive women
more likely to have preinvasive cervical lesions: low-grade squamous intraepithelial lesion (SIL)
(18.2% vs 4.4%; p < 0.001) and high-grade squamous intraepithelial lesion (12.1% vs 1.5%; p <
0.001).
Conclusion: We conclude that (i) sexually transmitted infections (STIs) are common in both HIV
positive and HIV negative pregnant women in Cameroon, and (ii) STIs and preinvasive cervical
lesions are more prevalent in HIV-infected pregnant women compared to their non-infected
compatriots. We recommend routine screening and treatment of STIs during antenatal care in
Cameroon and other countries with similar social profiles.
Introduction
There are three categories of reproductive morbidity –
obstetric, gynaecological and contraceptive morbidity.
Gynaecological morbidity has been defined as 'any condi-
tion, disease or dysfunction of the reproductive system
that is not related to pregnancy, abortion or childbirth but
may be related to sexual behaviour' [1].
Gynaecological conditions are frequent in women
infected with Human Immunodeficiency Virus (HIV).
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Reproductive Health 2008, 5:3 http://www.reproductive-health-journal.com/content/5/1/3Both pregnancy and HIV/AIDS predispose women to cer-
tain gynaecological conditions because of modification of
the immune system [2,3]. The Centers for Disease Control
and Prevention (CDC) classification system for HIV infec-
tion includes several gynaecological conditions such as
persistent, frequent or poorly responsive episodes of vagi-
nal candidiasis, moderate or severe cervical intraepithelial
neoplasia (CIN) and pelvic inflammatory disease (PID),
chronic herpes simplex virus ulcers and invasive cervical
cancer [4].
Korn and colleagues reviewed gynaecological disease in
women infected with HIV and identified five categories:
(i) lower genital tract neoplasia, (ii) pelvic inflammatory
disease, (iii) menstrual disorders, (iv) sexually transmit-
ted infections, (v) vaginitis and (vi) adverse effects of con-
traception [5].
Three of these categories are relevant in pregnancy,
namely lower genital tract neoplasia, sexually transmitted
infections and vaginitis. Pelvic inflammatory disease and
menstrual disorders are not conditions we encounter in
pregnancy.
Cameroon is one of the sub-Saharan African countries
with a high prevalence of HIV (6.8% among women of
reproductive age) [6]. Only HIV and syphilis are screened
routinely during antenatal care in Cameroon, despite the
fact that HIV is known to be associated with other sexually
transmitted infections [7]. After two decades of research
on HIV, the prevalence of gynaecological conditions
among HIV positive pregnant women is still unknown in
Cameroon.
Gynaecological morbidity in HIV infected pregnant
women has been largely ignored by research despite the
frequency and severity of these conditions [8]. Previous
research has focused mainly on gynaecological diseases in
HIV positive non-pregnant women [9].
The aim of this study was to describe the frequency of
gynaecological conditions among pregnant women and
to compare the prevalence of these conditions among HIV
positive and HIV negative pregnant women.
Methods
The study was conducted in a referral hospital (Yaounde
Central Hospital) in Cameroon between January 2006
and December 2006. The study was approved by the Eth-
ics Committee of the Faculty of Medicine and Biomedical
Sciences (University of Yaounde I).
All data were collected during the booking antenatal visit.
Pregnant women who received antenatal care during the
period of study and gave consent to participate in the
study were eligible for inclusion.
A detailed gynaecological and obstetrical history was
taken followed by a clinical examination during the book-
ing visit and any clinically detectable lesions were
recorded. Laboratory investigations were carried out for
gynaecological diseases known to be associated with HIV:
cervical intraepithelial lesions (CIN), sexually transmitted
infections and vaginitis. Only syphilis and HIV are
screened routinely during antenatal care in Cameroon.
Determine rapid test (Abbott Laboratories, IL, USA) was
used to screen for HIV. All reactive and doubtful samples
were confirmed with the Western Blot test. Vaginal swabs
were taken and a wet mount prepared in normal saline
immediately after collection and examined for the pres-
ence of clue cells, yeast cells and motile Trichomonal vagi-
nalis. Direct microscopic examination was performed on
Gram-stained genital swabs for the detection of leuko-
cytes and Gram-negative diplococci. Neisseria gonorrhea
was isolated by inoculation of the genital swab on modi-
fied Thayer Martin media followed by incubation in a can-
dle extinction jar at 36°C for 24–48 hour. Identification
of isolates was performed on the basis of colony morphol-
ogy, visualization of Gram-negative diplococci, positive
oxidase reaction and sugar fermentation tests. Bacterial
vaginosis was diagnosed according to Amsel criteria [10].
Candidiasis was diagnosed by isolation of the Gram-pos-
itive yeast-like cells on Saboraud's dextrose agar and con-
firmed by a positive germ tube test. Syphilis was
diagnosed if both Venereal Disease Research Laboratory
(VDRL) and Treponema Pallidum Hemagglutination
Assay (TPHA) were positive. A positive VDRL and negative
TPHA was considered false positive. A positive TPHA test
alone was interpreted as evidence of a past infection.
Chlamydia trachomatis was diagnosed by Micro Trak (Syva
Co., Palo Alto, Calif.) direct immunofluorescence test of
cervical scrapings [11].
Data was entered into SPSS Version 13. Descriptive statis-
tics such as proportions were analysed and presented.
Univariate analyses, using odds ratio (OR) and Chi-
square test for association were conducted to assess the
association between HIV status and gynaecological condi-
tions. All significance tests were two-tailed and statistical
significance was defined at the 5% alpha level.
Results
Two thousand and eight (2008) women participated in
the study. Six hundred and thirty eight women (31.8%)
had their booking visit during the first trimester, 1210
women (60.3%) during the second trimester and 160
women (8.0%) women during the third trimester.Page 2 of 5
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Socio-demographic characteristics of the study partici-
pants are shown in Table 1. The mean age was 28 years
(standard deviation [SD] = 9.1). A majority (58.0%) of the
women were aged 20–29 years. About 20.0% were nul-
liparous women, while 38.0% had four previous deliver-
ies or more. Most of them were married (58.0%) and had
secondary education or higher (58.2%). Up to 90.0% of
the study population came from urban area and the rest
were from rural areas closed to the capital city (Yaounde).
Prevalence of HIV
Of the 2008 women tested for HIV, 198 were HIV posi-
tive, giving an overall HIV prevalence of 9.9% among
pregnant women during their booking ANC visit.
Prevalence of gynaecological morbidity
The prevalence of gynaecological conditions among preg-
nant women by HIV status is presented in Table 2. All gen-
ital tract infections except candidiasis were more prevalent
among HIV positive compared to HIV negative women:
vaginal candidiasis (36.9% vs 35.4%), Trichomoniasis
(21.2% vs 10.6%), gonorrhoea (10.1% vs 2.5%), bacterial
vaginosis (21.2% vs 15.2%) and Chlamydia trachomatis
(38.4% vs 7.1%). The prevalence of syphilis was also
higher among HIV positive women (35.9% vs 10.6%).
Similarly, HIV positive women had a higher prevalence of
preinvasive cervical lesions: low-grade squamous intraep-
ithelial lesion (SIL) (18.2% vs 4.4%) and high-grade squa-
mous intraepithelial lesion (12.1% vs 1.5%).
Discussion
This study compared the prevalence of gynaecological
morbidity among pregnant women, according to their
HIV serostatus identified during antenatal care. Sexually
transmitted infections (STIs) and preinvasive cervical
lesions were found to be more prevalent among HIV
infected pregnant women compared to their non-infected
counterparts.
The high prevalence of STIs among HIV positive women
has previously been reported [5]. Sexually transmitted
infections producing ulcerative lesions such as syphilis,
chancroid and genital herpes simplex virus (HSV) are
associated with a higher rate of HIV transmission [5].
Non-ulcerative STIs are also associated with a three- to
five-fold increase in the risk of HIV acquisition [7]. Chais-
ilwattana et al (1997) reported a higher prevalence of gon-
orrhoea and Chlamydia trachomatis among HIV pregnant
women [12]. Gonorrhoea increases the risk for pelvic
inflammatory disease, infertility, ectopic pregnancy, and
acquisition and transmission of human immunodefi-
ciency virus (HIV) [13]. HIV infection and STIs have com-
mon risk factors, and STIs increase the risk of acquisition
of HIV. Some studies failed to find an association between
HIV and STIs, and this has been explained by insufficient
statistical power to detect the association [14].
It is not clear whether HIV infection increases the risk of
acquisition of vaginal infections, but these conditions are
common among sexually active women. Candida albucans
and other Candida species are known to cause sympto-
matic infections in women with certain risk factors such as
diabetes mellitus, broad spectrum antibiotics and immu-
Table 1: Socio-demographic characteristics of study population.










<20 years 25/198 (12.6) 380/1810 (21.0) 405/2008 (20.2)
20–29 years 120/198 (60.6) 1044/1810 (57.7) 1164/2008 (58.0)
≥ 30 years 53/198 (26.8) 386/1810 (21.3) 439/2008 (21.9)
Parity
0 30/198 (15.2) 375/1810 (20.7) 407/2008 (20.3)
1–3 78/198 (39.4) 766/1810 (42.3) 844/2008 (42.0)
≥ 4 90/198 (45.5) 667/1810 (36.9) 757/2008 (37.7)
Marital status
Single 75/198 (37.9) 769/1810 (42.5) 844/2008 (42.0)
Married 123/198 (62.1) 10571810 (58.4) 1164/2008 (58.0)
Education
No formal education 29/198 (14.6) 168/1810 (9.3) 197/2008 (9.8)
Primary 69/198 (34.8) 573/1810 (31.7) 642/2008 (32.0)
Secondary or higher 100/198 (50.5) 1069/1810 (59.1) 1169/2008 (58.2)
Residence
Rural 8/198 (4.0) 189/1810 (10.4) 196/2008 (9.8)
Urban 190/198 (96.0) 1622/1810 (89.6) 1812/2008 (90.2)Page 3 of 5
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quent in pregnancy. Leroy et al (1995) reported a similar
prevalence of vaginal candidiasis among HIV-infected
pregnant women (22.3%) and non-infected pregnant
women (20.1%) [15]. The prevalence of vaginal candidia-
sis in HIV-infected women depends on the CD4 count.
Burns et al (1997) reported a 3-fold increase in vaginal
candidiasis among HIV-infected women with low CD4
counts compared to HIV-infected women with normal
CD4 count during pregnancy [16]. Apart from Candida
spp, we reported an increase in the prevalence of bacterial
vaginosis (BV) among HIV pregnant women. Bacterial
vaginosis increases susceptibility to infection by HIV and
other genital tract pathogens, but it is not clear whether
HIV increases the risk of developing BV [17].
We reported an 8-fold increase in high grade SIL among
HIV infected pregnant women compared to their non-
infected compatriots. A 5-fold increase in cervical intraep-
ithelial neoplasia among HIV-infected women has been
described previously [5]. There is evidence that the sever-
ity of preinvasive cervical lesion is related to the degree of
immunosuppression, suggesting that immunosupprses-
sion contributes (at least in part) to the risk of developing
preinvasive lesion [18,19]. Some studies suggest that the
high prevalence of preinvasive cervical lesion may be
related to concurrent risk factors related to the mode of
transmission of HIV [20]. Ahr et al (2006) reported that
HIV positive women with low CD4 count had a higher
prevalence of human papilloma virus (HPV) and preinva-
sive cervical lesion was more frequent in women with
HPV [21]. HPV is a known causative agent for preinvasive
and invasive lesions of the cervix.
This study has some limitations. First of all, we relied on
clinically detectable lesions for the diagnosis of genital
herpes simplex virus and chancroid. Secondly, high levels
of cardiolipin antibodies associated with HIV infection
could interfere with serologic tests for syphilis and give
false positive results [5].
We conclude that (i) STIs are common in both HIV posi-
tive and HIV negative women in Cameroon, and (ii) STIs
and preinvasive cervical lesions are more prevalent in
HIV-infected pregnant women compared to their non-
infected compatriots. We recommend routine screening
and treatment of STIs during antenatal care in Cameroon
and countries with similar social profiles.
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